Literature DB >> 16412718

Fertility preservation in female cancer patients: current developments and future directions.

S Samuel Kim1.   

Abstract

OBJECTIVE: To review the current advances in fertility preservation strategies and to discuss future directions with an emphasis on ovarian tissue cryobanking.
DESIGN: The publications related to fertility preservation in cancer patients were identified through Medline and other bibliographic databases, focusing on the most recent developments. CONCLUSION(S): There are several options for fertility preservation in cancer patients. Even though most of them are still experimental and their efficacy and reliability have not been determined, the future of fertility preservation in women with cancer is promising. In particular, the recent report of a live birth after transplantation of human ovarian tissue has reinforced the clinical potential of ovarian tissue banking for fertility preservation. Many exciting studies are underway to improve the efficacy and solve the problems with current fertility preservation strategies. It is inevitable that we will see the emergence of more complex ethical problems with the application of new technologies to humans. However, continuous efforts to improve current strategies and to develop new strategies will benefit many women and children who are facing premature ovarian failure and sterility.

Entities:  

Mesh:

Year:  2006        PMID: 16412718     DOI: 10.1016/j.fertnstert.2005.04.071

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  36 in total

Review 1.  Breast cancer and fertility preservation.

Authors:  S Samuel Kim; Jennifer Klemp; Carol Fabian
Journal:  Fertil Steril       Date:  2011-01-26       Impact factor: 7.329

2.  Prospective study of depression and anxiety in female fertility preservation and infertility patients.

Authors:  Angela K Lawson; Susan C Klock; Mary Ellen Pavone; Jennifer Hirshfeld-Cytron; Kristin N Smith; Ralph R Kazer
Journal:  Fertil Steril       Date:  2014-08-22       Impact factor: 7.329

3.  Cancer treatment and fertility: a time to reassess realistic opportunities.

Authors:  J A García-Velasco; A Pellicer
Journal:  Clin Transl Oncol       Date:  2007-11       Impact factor: 3.405

Review 4.  Mechanisms controlling germline cyst breakdown and primordial follicle formation.

Authors:  Chao Wang; Bo Zhou; Guoliang Xia
Journal:  Cell Mol Life Sci       Date:  2017-02-14       Impact factor: 9.261

Review 5.  Challenges and Potential for Ovarian Preservation with SERMs.

Authors:  Alison Y Ting; Brian K Petroff
Journal:  Biol Reprod       Date:  2015-03-25       Impact factor: 4.285

6.  Ovarian Stimulation Is Safe and Effective for Patients with Gynecologic Cancer.

Authors:  Ruba A Akel; Xiaoyue M Guo; Molly B Moravek; Rafael Confino; Kristin N Smith; Angela K Lawson; Susan C Klock; Edward J Tanner Iii; Mary Ellen Pavone
Journal:  J Adolesc Young Adult Oncol       Date:  2020-01-10       Impact factor: 2.223

7.  The impact of vitrification on immature oocyte cell cycle and cytoskeletal integrity in a rat model.

Authors:  S Samuel Kim; Rachel Olsen; Dojun David Kim; David F Albertini
Journal:  J Assist Reprod Genet       Date:  2014-03-26       Impact factor: 3.412

8.  Allogeneic ovarian transplantation using immunomodulator preimplantation factor (PIF) as monotherapy restored ovarian function in olive baboon.

Authors:  Michael Feichtinger; Eytan R Barnea; Atunga Nyachieo; Mats Brännström; S Samuel Kim
Journal:  J Assist Reprod Genet       Date:  2017-11-11       Impact factor: 3.412

9.  Human ovarian tissue cortex surrounding benign and malignant lesions.

Authors:  Mary Ellen Pavone; Jennifer Hirshfeld-Cytron; Candace Tingen; Cristina Thomas; Jessina Thomas; M Patrick Lowe; Julian C Schink; Teresa K Woodruff
Journal:  Reprod Sci       Date:  2013-10-04       Impact factor: 3.060

Review 10.  Human oocyte and ovarian tissue cryopreservation and its application.

Authors:  Tao Tao; Alfonso Del Valle
Journal:  J Assist Reprod Genet       Date:  2008-08-01       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.